TCG Crossover Management

TCG Crossover Management as of June 30, 2026

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 54 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abivax Sa American Depositary Shares Comm (ABVX) 19.2 $801M 6.0M 133.26
Tango Therapeutics Comm (TNGX) 6.8 $284M 9.1M 31.26
Cg Oncology Comm (CGON) 6.3 $261M 3.7M 71.05
Cogent Biosciences Comm (COGT) 4.5 $188M 4.9M 38.70
Immunovant Comm (IMVT) 4.1 $172M 4.5M 38.53
Spyre Therapeutics Comm (SYRE) 4.1 $169M 1.9M 88.78
Dianthus Therapeutics Comm (DNTH) 3.9 $163M 1.7M 97.48
Mirum Pharmaceuticals Comm (MIRM) 3.0 $124M 1.1M 117.07
Zai Lab Ltd- Adrs (ZLAB) 2.8 $117M 6.1M 19.00
Amylyx Pharmaceuticals Comm (AMLX) 2.7 $112M 6.2M 17.96
Monte Rosa Therapeutics Comm (GLUE) 2.7 $112M 4.6M 24.20
Biocryst Pharmaceuticals Comm (BCRX) 2.6 $110M 11M 10.00
Vor Biopharma Comm (VOR) 2.5 $104M 5.7M 18.41
Tyra Biosciences Comm (TYRA) 2.5 $104M 3.2M 31.94
Dyne Therapeutics Comm (DYN) 2.5 $103M 4.6M 22.21
Disc Medicine Comm (IRON) 2.4 $98M 1.3M 73.14
Relay Therapeutics Comm (RLAY) 1.9 $80M 4.3M 18.71
Savara Comm (SVRA) 1.8 $76M 12M 6.16
Aura Biosciences Comm (AURA) 1.6 $68M 9.5M 7.10
Revolution Medicines Comm (RVMD) 1.5 $64M 341k 187.28
First Tracks Biotherapeutics Comm (TRAX) 1.4 $58M 2.9M 20.12
Kodiak Sciences Comm (KOD) 1.4 $56M 1.4M 38.96
Avalo Therapeutics Comm (AVTX) 1.3 $56M 3.0M 18.48
Lb Pharmaceuticals Comm (LBRX) 1.1 $47M 1.4M 32.45
Century Therapeutics Comm (IPSC) 1.0 $43M 18M 2.44
Tectonic Therapeutic Comm (TECX) 1.0 $41M 1.2M 34.38
Xencor Comm (XNCR) 0.9 $40M 2.5M 16.10
Surrozen Comm (SRZN) 0.9 $38M 1.5M 25.95
Editas Medicine Comm (EDIT) 0.9 $36M 11M 3.24
Mbx Biosciences Comm (MBX) 0.9 $36M 650k 55.20
Pharvaris Bv Comm (PHVS) 0.8 $35M 1.0M 34.58
Silence Therapeutics Adrs (SLN) 0.8 $33M 3.0M 10.98
Inflarx N V Comm (IFRX) 0.8 $33M 15M 2.24
Altimmune Comm (ALT) 0.7 $30M 10M 3.04
Janux Therapeutics Comm (JANX) 0.7 $28M 1.8M 15.36
Perspective Therapeutics Comm (CATX) 0.6 $27M 7.9M 3.41
Agomab Therapeutics Nv Adrs (AGMB) 0.6 $27M 2.1M 12.98
Biohaven Comm (BHVN) 0.6 $27M 1.8M 14.88
Aktis Oncology Comm (AKTS) 0.5 $23M 697k 32.23
Alector Comm (ALEC) 0.5 $20M 10M 2.01
Forte Biosciences Comm (FBRX) 0.5 $20M 920k 21.25
Monopar Therapeutics Comm (MNPR) 0.5 $19M 203k 92.59
Ocular Therapeutix Comm (OCUL) 0.4 $16M 1.6M 9.82
Adc Therapeutics Sa Comm (ADCT) 0.3 $12M 11M 1.07
Alx Oncology Holdings Comm (ALXO) 0.3 $12M 5.7M 2.07
Entrada Therapeutics Comm (TRDA) 0.2 $7.8M 1.1M 7.36
Cullinan Therapeutics Comm (CGEM) 0.2 $7.4M 407k 18.21
Arvinas Holding Comm (ARVN) 0.1 $5.9M 707k 8.31
Korro Bio Comm (KRRO) 0.1 $5.5M 416k 13.18
Research Alliance Corp Cl A Comm 0.1 $5.4M 500k 10.70
Leonabio Comm (LONA) 0.1 $4.3M 464k 9.19
Jatt Ii Acquisition Corp Comm 0.1 $2.3M 200k 11.36
Context Therapeutics Comm (CNTX) 0.0 $1.5M 2.7M 0.55
Eikon Therapeutics Comm (EIKN) 0.0 $495k 38k 13.05